Patents
CRISPR-PE System For Retinol Dehydrogenase 12 (Rdh12) Gene Mutations For Use In The Treatment Of Retinitis Pigmentosa (RP) Disease, pending, No: TR2021022284A2
Xeno Nucleic Acid Antisense-Oligonucleotide (XNA-ASO) Sequences for the Genetic Treatment of USH2A Induced Retinitis Pigmentosa Disease, pending, No: TR2022001648A2
Neural Lentiviral Vector Containing The Functional Abca4 Gene For Use In The Treatment Of Retinitis Pigmentosa (RP) Disease, pending, No: TR2022000448A2
Neurotrophic Factor And Optogenetic System-Based Lentiviral System For Use In Retinal Diseases, pending, No: TR2022021763A2
Methods for the Treatment of Spinal Muscular Atrophy, pending, No: WO2025144141A1